References
- Smith KA. Interleukin-2: Inception, impact, and implications. Science 1988; 234: 1169–1176
- Robb RJ. Interleukin 2: the molecule and its function. Immunol Today 1984; 5: 203–209
- Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172–3177
- Rosenberg SA, Grimm EA, McGrogan M, Doyle M, Kawasaki E, Koths K, Mark DF. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science 1984; 223: 1412–1414
- Wang A, Lu S-D, Mark DF. Site-specific mutagenesis of the human interleukin-2 gene: Structure-function analysis of the cysteine residues. Science 1984; 224: 1431–1433
- Gillis S, Perm MM, Ou W, Smith KA. T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 1978; 120: 2027–2032
- Kucharz EJ, Goodwin JS. Serum inhibitors of interleukin-2. Life Sci 1988; 42: 1485–1491
- Fukushima T, Kobayashi K, Kasama T, Kasahara K, Tabata M, Sekine F, Negishi M, Ide H, Takahashi T. Inhibition of interleukin 2 by serum in healthy individuals and in patients with autoimmune disease. Int Arch Allergy Appl Immunol 1987; 84: 135–141
- Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA. In vivo administration of purified human interleukin 2. 1. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol 1985; 134: 157–166
- Griffin DE, Ward BJ, Jauregui E, Johnson RT, Vaisberg A. Immune activation in measles. N Engl J Med 1989; 320: 1667–1672
- Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 1987; 139: 3802–3807
- Rubin LA, Jay G, Nelson DL. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 1986; 137: 3841–3844
- Boutin B, Matsuguchi L, Lebon P, Ponsot G, Arthuis M, Nelson DL. Soluble IL-2 receptors in acute and subacute encephalitis. Ann Neurol 1987; 22: 658–661
- Greenberg SJ, Marcon L, Hurwitz BJ, Waldmann TA, Nelson DL. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N Engl J Med 1988; 319: 1019–1020
- Gallo P, Piccinno M, Pagni S, Tavolato B. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1988; 24: 795–797